OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
810 - 789 West Pender Street
Vancouver, BC V6C 1H2
Canada
810 - 789 West Pender Street
Vancouver, BC V6C 1H2
Canada
Dr. Simons received her Ph.D. in Chemical Biology at the University of Ottawa and a Kellogg-Schulich Executive M.B.A. in operational business strategy. Dr. Simons is a quality and regulatory compliance professional in support of science study-backed cannabis product development, laboratory services, and data management tools for the development of safe cannabis. Presently, Dr. Brigitte Simons is the Chief Operating Officer at Safari Flower Co., a craft-at-scale licence cultivator in Fort Erie, Ontario.Dr. Simons is the Co-chair and Director of the Canadian C45 Quality Association and advocates in cannabis compliance policy and education to the regulatory agencies. Following on a strong network of laboratory service providers, having previously worked in cannabis field studies with with Molecular Science Corp., Dr. Simons established cannabis quality assurance remote support while craft growers navigate cultivator and processor partnerships with the Company to support the legacy brands entering into legal sales and distribution.
None
1140 West Pender Street
# 1500-1700
Vancouver, BC V6E EG1
Canada
Suite 2200, HSBC Building,
885 West Georgia Street
Vancouver, BC V6C 3E8
Canada
CRFT a curator and aggregator of craft cannabis, providing advocacy and access for premium small-batch growers to Canada’s cannabis market; Medcann Health Products – a cultivation and processing facility in Chemainus BC; Feelwell Brands, a successful cannabinoid brand house licensed in the state of California; and AVA Pathways a pre-clinical biotech company focused on neuroplasticity and mental health applications using psilocybin and compounds derived from mushrooms.
The company's subsidiary Medcann Health Products owns a cultivation and processing facility in Chemainus BC;